Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial-Reference-Cited by-同舟云学术

Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial

Published:2012-06 Issue:6 Volume:11 Page:503-511
ISSN:1474-4422
Container-title:The Lancet Neurology
language:en
Short-container-title:The Lancet Neurology

Author:

Easton J Donald,Lopes Renato D,Bahit M Cecilia,Wojdyla Daniel M,Granger Christopher B,Wallentin Lars,Alings Marco,Goto Shinya,Lewis Basil S,Rosenqvist Mårten,Hanna Michael,Mohan Puneet,Alexander John H,Diener Hans-Christoph

Publisher

Elsevier BV

Subject

Clinical Neurology

Reference33 articles.

1. Analysis of polled data from five randomized controlled trials;Arch Intern Med,1994

2. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study;Wolf;Stroke,1991

3. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis;Hart;Ann Intern Med,1999

4. Apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation (ARISTOTLE) trial: design and rationale;Lopes;Am Heart J,2010

5. Dabigatran versus warfarin in patients with atrial fibrillation;Connolly;N Engl J Med,2009

Cited by 257 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Residual Stroke Risk Among Patients With Atrial Fibrillation Prescribed Oral Anticoagulants: A Patient‐Level Meta‐Analysis From COMBINE AF;Journal of the American Heart Association;2024-09-03

2. Anticoagulation strategy for patients presenting with ischemic strokes while using a direct oral anticoagulant: A systematic review and meta-analysis;International Journal of Stroke;2024-08-09

3. Recurrent Ischemic Stroke in Patients With Atrial Fibrillation While Receiving Oral Anticoagulants;JAMA Neurology;2024-08-01

4. Embolic Stroke of Undetermined Source;Neurology;2024-07-09

5. Outcomes of non-vitamin K oral anticoagulants for secondary prevention in ischemic stroke with atrial fibrillation;Scientific Reports;2024-04-29